18:2 Lyso PA sodium is a long-chain unsaturated lysophosphatidic acid (LysoPA) subtype. 18:2 Lyso PA sodium shows a significant correlation with total autotaxin (ATX) in peripheral arterial plasma. 18:2 Lyso PA sodium serves as a biomarker for acute coronary syndrome (ACS) and can be used in research related to acute coronary syndrome (ACS)[1][2].
Molekulargewicht:
456.49
Formel:
C21H38NaO7P
Target-Kategorie:
Endogenous Metabolite
Anwendungsbeschreibung:
MCE Product type: Natural Products
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
